Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1120 | 1120 | 1170 | 1442 | 1678 | 2485 |
Fund Return | 12.04% | 12.04% | 17.04% | 12.97% | 10.91% | 9.53% |
Place in category | 695 | 695 | 924 | 570 | 562 | 328 |
% in Category | 32 | 32 | 46 | 33 | 37 | 34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LansfOrsakringar Global Indexnara | 96.27B | 15.53 | 16.22 | 14.89 | ||
Lansforsakringar USA Indexnara | 37.84B | 17.28 | 19.15 | 18.16 | ||
Lansforsakringar Sverige Indexnara | 35.37B | 6.84 | 5.03 | 9.77 | ||
Lansforsakringar Global Hallbar A | 24.38B | 20.43 | 15.34 | 13.06 | ||
Lansforsakringar Global Hallbar B | 24.38B | 20.52 | 15.67 | 13.30 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Handelsbanken Europafond Index | 20.24B | 11.56 | 12.59 | 9.59 | ||
Handelsbanken European Index utd | 20.24B | 11.56 | 12.59 | 9.11 | ||
SPP Aktiefond Europa | 17.07B | 11.53 | 13.07 | 9.68 | ||
Swedbank Robur Access Europa | 14.32B | 15.69 | 15.26 | 9.92 | ||
FI4000048988 | 10.17B | 9.87 | 11.48 | 9.88 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.64 | 866.8 | -1.35% | |
ASML Holding | NL0010273215 | 5.33 | 833.70 | -0.13% | |
Louis Vuitton | FR0000121014 | 3.36 | 778.00 | -2.77% | |
Nestle | CH0038863350 | 3.21 | 92.08 | -2.02% | |
AstraZeneca | GB0009895292 | 3.04 | 12,026.0 | +5.94% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review